| Literature DB >> 24278502 |
You-Jin Choi1, Hu-Quan Yin, Eun-Jung Park, Kwangsik Park, Dae-Seon Kim, Byung-Hoon Lee.
Abstract
As the frequency and the intensity of so called Asian dust (AD) events have increased, public concerns about the adverse health effects has spiked sharply over the last two decades. Despite the recent reports on the correlation between AD events and the risk for cardiovascular and respiratory disease, the nature of the toxicity and the degree of the risk are yet largely unknown. In the present study, we investigated the effects of the dichloromethane extract of AD (AD-X) and that of urban dust (NAD-X) collected during a non-AD period on gene expression in HL-60 cells using Illumina Sentrix HumanRef-8 Expression BeadChips. Global changes in gene expression were analyzed after 24 h of incubation with 50 or 100 μg/ml AD-X and NAD-X. By one-way analysis of variance (p < 0.05) and Benjamini-Hochberg multiple testing correction for false discovery rate of the results, 573 and 297 genes were identified as AD-X- and NAD-X-responsive, respectively. The genes were classified into three groups by Venn diagram analysis of their expression profile, i.e., 290 AD-X-specific, 14 NAD-X-specific, and 283 overlapping genes. Quantitative realtime PCR confirmed the changes in the expression levels of the selected genes. The expression patterns of five genes, namely SORL1, RABEPK, DDIT4, AZU1, and NUDT1 differed significantly between the two groups. Following rigorous validation process, these genes may provide information in developing biomarker for AD exposure.Entities:
Keywords: Air pollution; Asian dust; Biomarker; HL-60 cells; Microarray
Year: 2010 PMID: 24278502 PMCID: PMC3834465 DOI: 10.5487/TR.2010.26.1.021
Source DB: PubMed Journal: Toxicol Res ISSN: 1976-8257
Gene specific primers used in quantitative real-time PCR
| Gene | NCBI RefSeq | Forward primer (5'-3') | Reverse primer (5'-3') |
|---|---|---|---|
|
| |||
| AZU1 | NM_001700.3 | 5' GTGGTGCTGGGTGCCTATGAC 3' | 5' CACGCTGCTGGTGAGGTTGG 3' |
| RP11-529I10.4 | NM_015448.1 | 5' AAGGAAAGCAATGCCAATC 3' | 5' AGGCGTCATCCAGAGGTAG 3' |
| NUDT1 | NM_198954.1 | 5' GGCTCTATACCCTGGTGCTG 3' | 5' TCCTGACCCTGGAACTTGA 3' |
| RABEPK | NM_005833.2 | 5' CTGACCGTATCTGGGTATTT 3' | 5' CTGCCATTTCATGTCACTTAT 3' |
| ARMET | NM_006010.2 | 5' TACCAGGACCTCAAAGACAG 3' | 5' GGGCATATTTAGGCATCAGT 3' |
| FLJ10081 | NM_017991.3 | 5' CGCAGCGTGATGAATGAGT 3' | 5' GCAGATGGGTGGCTACAGG 3' |
| CSTB | NM_000100.2 | 5' GTTTAAGGCCGTGTCATTC 3' | 5' CTTGGCTTTGTTGGTCTGG 3' |
| CD55 | NM_000574.2 | 5' AAATCATGCCCTAATCCG 3' | 5' CTGCCTGAAATAAGACAAA 3' |
| DDIT4 | NM_019058.2 | 5' CTCTTCGCCCTCGTCCTT 3' | 5' AGCCAGTGCTCAGCGTCA 3' |
| GAPDH | NM_002046.3 | 5' AACGGATTTGGTCGTATTG 3' | 5' GCTCCTGGAAGATGGTGAT 3' |
Fig. 1.Acute cytotoxicity of AD-X and NAD-X in human promyelocytic leukemia cells (HL-60) . The cells were incubated with increasing concentrations of AD-X or NAD-X in media containing 10% fetal bovine serum for 24 h after which viability was determined by MTT assay. Results are expressed as the percentage of viable cells compared to solvent controls.
Top 10 up- and down-regulated genes (one-way ANOVA; p≺0.05) compared with control in the HL-60 cells treated with ADX
| NCBI ref | Gene symbol | p-value | Fold change AD50 | Fold change AD100 | Panther Process |
|---|---|---|---|---|---|
|
| |||||
| NM_002777.3 | PRTN3 | 0.01 | -1.99 | -6.51 | PM |
| NM_152851.1 | MS4A6A (transcript variant 3) | 0.01 | -3.14 | -4.23 | unclassified |
| NM_022349.2 | MS4A6A (transcript variant 2) | 0.01 | -3.52 | -4.01 | unclassified |
| NM_005218.3 | DEFB1 | 0.01 | -2.03 | -3.68 | ID |
| NM_001972.2 | ELA2 | 0.01 | -0.98 | -3.19 | PM; ID |
| NM_020070.2 | IGLL1 | 0.01 | -1.31 | -3.04 | ID |
| NM_001700.3 | AZU1 | 0.01 | -1.18 | -3.02 | PM |
| NM_000647.3 | CCR2 | 0.01 | -2.46 | -2.94 | ST; ID; CS |
| NM_004772.1 | C5orf13 | 0.01 | -2.14 | -2.80 | unclassified |
| NM_003039.1 | SLC2A5 | 0.01 | -0.69 | -2.75 | CM; T |
| NM_000903.2 | NQO1 | 0.01 | 2.44 | 3.80 | unclassified |
| NM_005980.2 | S100P | 0.01 | 2.36 | 3.92 | unclassified |
| NM_052815.1 | IER3 | 0.01 | 0.79 | 3.92 | ID |
| NM_000265.1 | NCF1 | 0.01 | 1.80 | 3.99 | ET; ST |
| NM_001423.1 | EMP1 | 0.01 | 0.42 | 4.21 | AP; DP; CC; CP; O |
| NM_000584.2 | IL8 | 0.01 | 3.14 | 4.28 | ST; ID; DP; CP; CS |
| NM_015991.1 | C1QA | 0.01 | 3.78 | 4.31 | ID |
| NM_000576.2 | IL1B | 0.01 | 1.41 | 4.43 | ST; ID; AP; CC; CP |
| NM_000591.1 | CD14 | 0.01 | 1.09 | 4.81 | ID |
| NM_002982.3 | CCL2 | 0.01 | 2.18 | 4.93 | ST; ID |
Values represent fold changes on log2 scale compared with control groups. AP, Apoptosis; CC, Cell cycle; CM, Carbohydrate metabolism; CP, Cell proliferation and differentiation; CS, Cell structure and motility; DP, Developmental processes; ET, Electron Transport; ID, Immunity and defense; O, Oncogenesis; PM, Protein metabolism & modification; ST, Signal transduction; T, Transport.
Top 10 up- and down-regulated genes (one-way ANOVA; p≺ 0.05) compared with control in the HL-60 cells treated with NAD-X
| NCBI ref | Gene symbol | p-value | Fold change NAD50 | Fold change NAD100 | Panther Process |
|---|---|---|---|---|---|
|
| |||||
| NM_002777.3 | PRTN3 | 0.01 | -1.61 | -4.47 | PM |
| NM_152851.1 | MS4A6A (transcript variant 3) | 0.01 | -3.04 | -4.00 | unclassified |
| NM_022349.2 | MS4A6A (transcript variant 2) | 0.01 | -3.31 | -3.93 | unclassified |
| NM_020070.2 | IGLL1 | 0.01 | -1.18 | -3.42 | ID |
| NM_005218.3 | DEFB1 | 0.01 | -1.76 | -3.28 | ID |
| NM_000647.3 | CCR2 | 0.01 | -2.33 | -2.74 | ST; ID; CS |
| NM_001700.3 | AZU1 | 0.01 | -1.13 | -2.43 | PM; ID |
| NM_004772.1 | C5orf13 | 0.01 | -2.08 | -2.41 | unclassified |
| NM_015166.2 | MLC1 | 0.01 | -0.69 | -2.41 | unclassified |
| NM_002163.2 | IRF8 | 0.02 | -1.92 | -2.29 | NM; ID;O |
| NM_005248.1 | FGR | 0.01 | 1.40 | 3.02 | CM; PM; ST; ID; DP; CC; CP; O |
| NM_019058.2 | DDIT4 | 0.03 | 1.88 | 3.03 | unclassified |
| NM_000903.2 | NQO1 | 0.01 | 2.13 | 3.06 | unclassified |
| NM_022718.2 | MMP25 | 0.01 | 1.63 | 3.18 | PM |
| NM_005980.2 | S100P | 0.01 | 2.29 | 3.43 | unclassified |
| NM_000591.1 | CD14 | 0.01 | 0.65 | 3.44 | ID |
| NM_012387.1 | PADI4 | 0.01 | 1.48 | 3.62 | PM |
| NM_015991.1 | C1QA | 0.01 | 3.56 | 3.68 | ID |
| NM_000584.2 | IL8 | 0.02 | 2.99 | 3.88 | ST; ID; DP; CP; CS |
| NM_002982.3 | CCL2 | 0.02 | 1.72 | 4.17 | ST; ID |
Values represent fold changes on log2 scale compared with control groups. CC, Cell cycle; CM, Carbohydrate metabolism; CP, Cell proliferation and differentiation; CS, Cell structure and motility; DP, Developmental processes; ID, Immunity & defense; NM, Nucleoside, nucleotide and nucleic acid metabolism; O, Oncogenesis; PM, Protein metabolism & modification; ST, Signal transduction.
Fig. 2.Flowchart for data analysis and Venn diagram analysis. (A) The microarray data were analyzed by one-way ANOVA adjusted by the Benjamini-Hochberg multiple testing correction and subjected to a cutoff of twofold or greater induction or repression. AD and NAD indicate Asian dust and non-Asian dust respectively and the numbers after the symbol indicate the dose of the sample in mg/ml. (B) Venn diagram analysis was performed with data obtained from the analysis as described in Fig. 2A. Numbers in each complete circle denote the total numbers of up- and downregulated genes to the indicated treatment; those in the overlapping region depict the number of shared genes between the two treatment conditions.
Fig. 3.Classification of gene function and hierarchical cluster analysis of differentially expressed genes. (A) The data of altered genes from exposure to AD-X or NAD-X in HL-60 cells were analyzed using Panther database (http://www.pantherdb.org) . Representative biological processes are indicated in each group. (B) The analysis was performed on 587 genes obtained by adjusting the data using the Benjamini-Hochberg multiple test correction with a twofold cutoff. Red and green colors in the matrix indicate relative gene induction and repression respectively. The dendrogram groups genes according to overall similarities in the gene expression profile.
Quantitative real-time PCR validation of selected genes from microarray data in AD-X 100 group
| Gene | Microarray | qRT-PCR |
|---|---|---|
|
| ||
| AZU1 | -3.05 ± 0.01 | -2.20 ± 0.10 |
| RP11-529I10.4 | -1.18 ± 0.03 | -0.99 ± 0.73 |
| NUDT1 | -1.17 ± 0.01 | -0.72 ± 0.21 |
| RABEPK | -1.11 ± 0.03 | -1.34 ± 0.79 |
| ARMET | -0.30 ± 0.07 | -0.06 ± 0.18 |
| FLJ10081 | 0.25 ± 0.04 | -0.50 ± 0.04 |
| CSTB | 1.46 ± 0.01 | 1.87 ± 0.93 |
| CD55 | 2.36 ± 0.06 | 1.40 ± 0.02 |
| DDIT4 | 3.41 ± 0.07 | 5.69 ± 0.40 |
Data are expressed as fold-changes in a log2 scale compared to the control groups.
Fig. 4.Fold induction or repression of selected biomarker genes in HL-60 cells exposed to AD-X or NAD-X. The expression level of each gene was assessed by Q-PCR and normalized against GAPDH. Data are expressed as fold changes in a log2 scale compared to the corresponding control groups. Statistically significant differences between the two groups are indicated by an asterisk (*p<0.05) .